Improving the Treatment of Anorexia Nervosa in Children Through Virtual Reality Body Exposure
EOAN-VR-ABM
1 other identifier
interventional
108
1 country
1
Brief Summary
The age of onset of anorexia nervosa has been progressively decreasing in recent years. Also, the prevalence rates of childhood anorexia in many countries have grown significantly. This increase was already observed before the COVID-19 pandemic, but the confinements and the stress derived from them have caused this increase to accelerate. As in adolescent and adult patients, in childhood anorexia some of the core signs and symptoms are an extreme fear of gaining weight and avoidance of food. The consequences of the early-onset of anorexia can be very important since the maturation of the organism is more incomplete in children than in adolescents. Weight loss can have very severe consequences, since in children the percentage of body fat is lower. On the other hand, hormonal disorders derived from food deprivation also have very severe consequences for the development of different organs. General physical development and growth can be affected, with consequences such as not being able to reach normal height. The research carried out to date on the efficacy of treatments for childhood anorexia is very scarce. There are no specific treatment strategies or settings for children with anorexia, and little research has been done to tailor treatment for younger patients. Given the need to explore new treatments for anorexia nervosa specifically aimed at children, the objective of this project is to develop a program to carry out exposure to one's own body through virtual reality, gradually, with progressive increases in size until achieving a healthy weight. In the virtual exposure, patients will observe the image of an avatar in a mirror for the time necessary in each session to produce the reduction of the anxiety response. The avatars that will be developed for this purpose will have a physical constitution corresponding to children under 14 years of age, and physical proportions equivalent to those of each patient. The positive results obtained with a previous version of this treatment originally developed for adolescents and adults suggest that its adaptation to children can open new ways for exploring effective treatments for childhood anorexia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2023
CompletedFirst Posted
Study publicly available on registry
December 12, 2023
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2026
May 1, 2026
April 1, 2026
2.5 years
December 4, 2023
April 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Eating Disorder symptomatology: Eating Disorders Inventory-3 (EDI-3; Garner, 2004) drive for thinness (EDI-DT) scale
Evaluation of the change in drive for thinness, with maximum possible score of 28, where higher scores indicate higher drive for thinness.
From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up
Change in Eating Disorder symptomatology: Eating Disorders Inventory-3 (EDI-3; Garner, 2004) body dissatisfaction (EDI-BD) scale
Evaluation of the change in body dissatisfaction, with maximum possible score of 40, where higher scores indicate higher body dissatisfaction.
From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up
Change in body mass index values
Evaluation of change in Body Mass Index values
From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up
Secondary Outcomes (6)
Change in Body Anxiety: Physical Appearance State Anxiety Scale (PASTAS)
From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up
Change in Body image disturbance: Body Appreciation Scale (BAS)
From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up
Change in Body image disturbance: Figural Drawing Scale for Body Image Assessment (BIAS-BD) body distortion scores
From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up
Change in Body image disturbance: Figural Drawing Scale for Body Image Assessment (BIAS-BD) body dissatisfaction scores
From pre-assessment to post-assessment after 6 weeks , and at the six-month follow-up
Change in complete fixation time of the gaze towards weight-related body parts
From pre-assessment to post-assessment after 6 weeks
- +1 more secondary outcomes
Other Outcomes (3)
Body-related anxiety
Up to 40 minutes. Baseline (prior to beginning the body exposure session), every two minutes during the exposure, and at the end of the body exposure session
Fear of gaining weight
Up to 40 minutes. Baseline (prior to beginning the body exposure session) and at the end of the body exposure session
Full body ownership illusion
Up to 40 minutes. Baseline (prior to beginning the body exposure session) and at the end of the body exposure session
Study Arms (3)
Cognitive-behavioral therapy plus VR-based body exposure and Attentional Bias Modification Training.
EXPERIMENTALIn this group, five sessions of VRE will be added to the usual CBT, as in the other experimental group, but, in addition, at the beginning of each of the exposure sessions, the training aimed at reducing the attentional bias will be carried out. The training will be developed through the visual selection of geometric figures that fit approximately with specific parts of the body. Each of these figures can have different colors. Specifically, the patient must detect and identify the figures that will appear in different parts of the avatar's body. In half of the trials, the shape of the figure must be discriminated and in the remaining 50%, the discrimination will be based on color. Throughout the training, the geometric figures will appear on weight-related body parts in 45% of the trials, and in another 45% of the trials, it will appear on non-weight-related body parts. In the remaining trials (10%), the test will appear on one of three neutral stimuli located next to the avatar.
Cognitive-behavioral therapy for anorexia and VR-based body exposure:
EXPERIMENTALPatients assigned to this group will receive the usual CBT from the clinical unit or the hospital where they are, and additionally, five sessions of VR-based body exposure intervention. In these weekly sessions patients will go through a body exposure intervention in which they will own a virtual avatar with their real measurements, that will progressively increase its BMI values throughout the following exposure sessions until a healthy BMI value is reached.
Cognitive behavioral therapy
ACTIVE COMPARATORPatients assigned to this group will receive the usual treatment from the center in which they are recruited for the study (CBT), and will have to complete the evaluations following the same schedule as the experimental group.
Interventions
Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions and five sessions of Attentional Bias Modification Training.
Combine usual cognitive-behavioral treatment (CBT) sessions with additional five VR-based body-exposure therapy sessions
Usual cognitive-behavioral treatment (CBT) sessions.
Eligibility Criteria
You may qualify if:
- Patients with a primary diagnosis of anorexia nervosa (DSM-V)
- Patients below 14 years old
- Patients with BMI \<18.5
- Subsyndromal patients will also be included
You may not qualify if:
- Visual deficits
- Epilepsy or neuroleptic medication
- Psychotic disorder
- Bipolar disorder
- Medical complications
- Pregnancy
- Clinical cardiac arrhythmia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Sant Joan de Deucollaborator
- University of Barcelonalead
Study Sites (1)
Hospital Sant Joan de Déu
Barcelona, Barcelona, 08950, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
José Gutiérrez-Maldonado
University of Barcelona
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 4, 2023
First Posted
December 12, 2023
Study Start
July 1, 2024
Primary Completion (Estimated)
December 30, 2026
Study Completion (Estimated)
December 30, 2026
Last Updated
May 1, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
The data presented in this study will be available on request from the corresponding author. The data are not publicly available due to patients' privacy restrictions.